Search alternatives:
significant point » significant amount (Expand Search), significant part (Expand Search), significant event (Expand Search)
clinical disease » tropical disease (Expand Search), clinical cases (Expand Search)
point decrease » point increase (Expand Search)
Showing 1 - 20 results of 70,166 for search '(( significant point decrease ) OR ( significant clinical disease ))', query time: 0.54s Refine Results
  1. 1
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Comparison of clinical parameters at baseline (pre-treatment) and the point of clinical resolution after intravitreal methotrexate injection.

    Comparison of clinical parameters at baseline (pre-treatment) and the point of clinical resolution after intravitreal methotrexate injection. by Rae-Young Kim (11747549)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 5
    Summary of the earliest time point for significant WD-induced changes in NASH-associated markers.

    Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. by Melinda H. Spooner (6551933)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 6
    Baseline patient demographics and clinical characteristics.

    Baseline patient demographics and clinical characteristics. by Martin Wasserbauer (6239699)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 7
    Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR.

    Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. by Jordan A. Gunning (18143970)

    Published 2024
    Save to List
    Saved in:
  8. 8
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Clinical and radiologic features of patients with Covid-19 and control group.

    Clinical and radiologic features of patients with Covid-19 and control group. by Sam Alahyari (12645313)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 11
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Prevalence and clinical significance of granulomas in Crohn's disease anal fistula

    Prevalence and clinical significance of granulomas in Crohn's disease anal fistula by Huihui Wu (18394758)

    Published 2024
    Save to List
    Saved in:
  14. 14
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Determination of the ventilatory threshold (VT) point.

    Determination of the ventilatory threshold (VT) point. by Kazufumi Hisamoto (21416905)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Classification of patients according to 25-point CT severity score.

    Classification of patients according to 25-point CT severity score. by Ahmed Ismail (2671822)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 17
    Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity.

    Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Variants assigned Clinvar pathogenic clinical significance.

    Variants assigned Clinvar pathogenic clinical significance. by Anastasiia Buianova (19871022)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 19
    Clinical significance test.

    Clinical significance test. by Olive M. Fast (6655304)

    Published 2019
    Save to List
    Saved in:
  20. 20
    Variants with an unknown significance or conflicting interpretation of clinical significance.

    Variants with an unknown significance or conflicting interpretation of clinical significance. by J. Tyson McDonald (3687694)

    Published 2022
    Save to List
    Saved in:

Search Tools: